Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 5:5:1405836.
doi: 10.3389/falgy.2024.1405836. eCollection 2024.

Editorial: 2022 in review: rhinology

Diego M Conti  1   2 , Glenis K Scadding  3   4
Affiliations
Editorial

Editorial: 2022 in review: rhinology

Diego M Conti et al. Front Allergy. .
No abstract available

Keywords: AERD; EUFOREA; allergic rhinitis; chronic rhinosinusitis; common cold; facial mask; nasal polyp syndrome; rhinology.

PubMed Disclaimer

Conflict of interest statement

DC: Serves as Academic Manager at the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) and as Review Editor at Frontiers in Allergy, Rhinology Section. GS: Honoraria for articles, speaker and advisory boards: ALK, Bayer, Chiesi, GlaxoSmithKline, Haleon, Noucor, Sanofi- Regeneron, and Viatris. Chair of BSACI rhinitis guidelines, Scientific Chief Editor, Rhinology Section of Frontiers in Allergy, Vice President and AR lead for EUFOREA, and Chair/ member Data Monitoring Committees on SLIT for ALK. Scientific Chief Editor, Rhinology Section, Frontiers in Allergy. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

References

    1. De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, et al. White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA. Front Allergy. (2022) 3:889221. 10.3389/falgy.2022.889221 - DOI - PMC - PubMed
    1. Pugin B, Deneyer L, Bachert C, Alobid I, Bousquet J, De Carlo G, et al. Patient advisory board for chronic rhinosinusitis—a EUFOREA initiative. Rhinology. (2019) 57(5):331–5. 10.4193/Rhin19.012 - DOI - PubMed
    1. Claeys N, Teeling MT, Legrand P, Poppe M, Verschueren P, De Prins L, et al. Patients unmet needs in chronic rhinosinusitis with nasal polyps care: a patient advisory board statement of EUFOREA. Front Allergy. (2021) 2:761388. 10.3389/falgy.2021.761388 - DOI - PMC - PubMed
    1. Hellings PW, Fokkens WJ, Orlandi R, Adriaensen GF, Alobid I, Baroody FM, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhinology. (2023) 61(1):85–9. 10.4193/Rhin22.344 - DOI - PubMed
    1. Hellings PW, Scadding G, Bachert C, Bjermer L, Canonica GW, Cardell LO, et al. EUFOREA treatment algorithm for allergic rhinitis. Rhinology. (2020) 58(6):618–22. 10.4193/Rhin20.246 - DOI - PubMed

Publication types

LinkOut - more resources